GYRE THERAPEUTICS, INC. - COM (GYRE) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / COM
Symbol
GYRE on Nasdaq
Price per share
$7.57
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
3,125,837
Total reported value
$22,068,897
% of total 13F portfolios
0%
Share change
+296,118
Value change
+$2,085,587
Number of holders
30
Price from insider filings
$7.57
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 31 Dec 2025, 30 institutional investors reported holding 3,125,837 shares of GYRE THERAPEUTICS, INC. - COM (GYRE).

Institutional Holders of GYRE THERAPEUTICS, INC. - COM (GYRE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 3,125,837 $22,068,897 +$2,085,587 $7.06 30
2025 Q3 3,095,667 $23,092,842 -$2,342,158 $7.46 46
2025 Q2 3,409,744 $25,061,360 +$5,853,522 $7.35 46
2025 Q1 2,609,308 $20,144,142 +$6,336,492 $7.72 43
2024 Q4 1,787,607 $21,632,748 +$928,321 $12.10 38
2024 Q3 1,610,238 $20,192,706 +$4,240,434 $12.54 34
2024 Q2 1,257,751 $15,006,266 +$4,350,927 $11.93 30
2024 Q1 816,435 $14,271,940 +$3,243,845 $17.48 19
2023 Q4 606,775 $15,589,189 +$15,582,192 $25.69 15